Generated by GPT-5-mini| Stroke (journal) | |
|---|---|
| Title | Stroke |
| Discipline | Neurology |
| Abbreviation | Stroke |
| Publisher | American Heart Association |
| Country | United States |
| Frequency | Monthly |
| History | 1970–present |
Stroke (journal) is a monthly peer-reviewed medical journal published by the American Heart Association focusing on cerebrovascular disease, clinical neurology, and neurovascular research. The journal publishes original research, reviews, guidelines, and editorials that inform clinical practice and health policy across institutions such as the Mayo Clinic, Johns Hopkins, Cleveland Clinic, Massachusetts General Hospital, and University of California. Authors affiliated with Harvard Medical School, Stanford University, University of Oxford, University of Cambridge, and Karolinska Institutet have contributed to its corpus, influencing practice in settings including the World Health Organization, Centers for Disease Control and Prevention, and National Institutes of Health.
The journal was established in 1970 under the auspices of the American Heart Association, growing alongside developments at institutions such as Columbia University, Yale University, University of Pennsylvania, and University of Toronto. Its early issues reflected advances from investigators at Rockefeller University, Cedars-Sinai Medical Center, and University of Chicago, paralleling milestones like the development of computed tomography at Massachusetts General Hospital and magnetic resonance imaging innovations at University of California, San Francisco. Over decades the journal published landmark work connected to trials and consortia including the National Institutes of Health Stroke Trial Network, European Stroke Organisation, and the Global Burden of Disease study, while engaging contributors from King's College London, Imperial College London, Karolinska Institutet, and Tokyo University.
The journal covers clinical trials, translational research, epidemiology, imaging studies, and therapeutic interventions related to ischemic stroke, hemorrhagic stroke, transient ischemic attack, and vascular cognitive impairment. Typical submissions analyze data from randomized controlled trials run by groups such as the International Stroke Trial, SITS-MOST, and INTERACT, and apply methodologies developed at institutions like Johns Hopkins, University of Michigan, University of California San Diego, and University of Washington. Review articles synthesize findings relevant to guideline panels convened by the American Heart Association, European Society of Cardiology, World Stroke Organization, and American Academy of Neurology, and reference registries such as Get With The Guidelines, Canadian Stroke Network, Swedish Stroke Register, and Australian Stroke Clinical Registry.
Published monthly, the journal is produced by the American Heart Association and distributed to subscribers including hospitals like Mount Sinai, Brigham and Women's Hospital, and Royal Melbourne Hospital. It is indexed in bibliographic databases managed by Elsevier, Clarivate Analytics, and PubMed Central, and appears in indexes used by the National Library of Medicine, Scopus, and EMBASE. Digital archives integrate with platforms used by academic libraries at Princeton University, University of Chicago, University of Toronto, and University of Sydney, and the journal participates in initiatives involving CrossRef, ORCID, and the Committee on Publication Ethics.
The editorial board comprises clinicians and scientists from leading centers including Cleveland Clinic, Mayo Clinic, University College London, Erasmus University Medical Center, and Peking University. Senior editors coordinate peer review workflows with associate editors and statistical reviewers from institutions such as Vanderbilt University, University of Pennsylvania, and Northwestern University. The journal employs double-blind and open peer review elements aligned with policies from COPE and ICMJE, and editors collaborate with guideline authors from the American Heart Association, European Stroke Organisation, and World Stroke Organization when commissioning state-of-the-art reviews and position papers.
The journal's articles contribute to citation networks tracked by Clarivate's Web of Science, Scopus metrics, and Google Scholar profiles maintained by researchers at Harvard Medical School, University of Cambridge, and University of Oxford. Impact is reflected in guideline citations by the American Heart Association, European Stroke Organisation guidelines, and inclusion in systematic reviews by Cochrane Collaboration and Campbell Collaboration authors. The journal's influence extends to policy documents from the World Health Organization, Centers for Disease Control and Prevention, and national health ministries in the United Kingdom, Canada, Australia, and Japan.
Notable publications include randomized trials and meta-analyses influencing reperfusion therapy and blood pressure management, authored by investigators from institutions such as University of California San Francisco, Massachusetts General Hospital, University of Oxford, and Karolinska Institutet. Seminal cohort studies on stroke epidemiology have drawn on data from the Framingham Heart Study, Atherosclerosis Risk in Communities, REGARDS study, and INTERSTROKE consortium. Imaging and biomarker papers have involved collaborators from Imperial College London, UCLA, Johns Hopkins, and Tokyo Metropolitan Institute of Medical Science, while health services research and implementation papers have engaged teams from RAND Corporation, RTI International, and the Agency for Healthcare Research and Quality.
Category:Neurology journals Category:American Heart Association academic journals